(Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Feb 28, 2022 | (FY)Dec 31, 2021 | (Q3)Nov 30, 2021 | (Q2)Aug 31, 2021 | (Q1)May 31, 2021 | (Q4)Feb 28, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -105.81K | -1.1M | -823.9K | 93.31%-219.31K | 28.33%-2.37M | -691.27%-3.28M | -342.38%-423.29K | -215.04%-269.41K | -193.83%-643.32K | -647.38%-3.3M |
Net income from continuing operations | --2.99M | ---1.12M | ---1.66M | -282.06%-15.9M | 67.50%-1.15M | -208.05%-4.16M | -316.28%-1.5M | -285.86%-1.08M | -225.69%-634.6K | -237.92%-3.53M |
Operating gains losses | --2.55K | ---- | ---- | ---- | 5.47%-902.87K | ---912.6K | 93.43%-36 | ---- | ---- | ---955.07K |
Depreciation and amortization | --1.18M | --1.16M | --916.64K | 186.38%1.81M | --359.31K | 1,058.24%631.47K | --298.83K | --166.97K | --16.66K | ---- |
Asset impairment expenditure | --0 | --0 | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | --0 | 99.98%-32 | -205.97%-6.87K | -100.02%-25 | 131.71%5.22K | -114.27%-12.05K | -1,534.06%-211.55K |
Remuneration paid in stock | --264.64K | --391.57K | --345.52K | 41.48%1.28M | -58.64%438.57K | 4,015.96%903.95K | 322.68%292.49K | 702.57%446.21K | 70.33%19.09K | 7,281.53%1.06M |
Deferred tax | --0 | ---- | ---- | ---3.18M | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cashItems | ---3.82M | ---915.75K | --299.96K | 15,427.40%12.97M | ---5.8M | --83.52K | --98.61K | --41.39K | --6.43K | ---- |
Change In working capital | ---726.9K | ---635.96K | ---723.29K | 1,749.94%2.8M | -177.81%-723.68K | -79.74%151.18K | 549.53%390.54K | 5.32%165.79K | 76.20%-38.85K | -156.48%-260.5K |
-Change in receivables | --1.14M | ---3.2M | ---1.14M | 204.93%1.66M | ---1M | -432.42%-1.58M | ---273.84K | ---598.28K | ---193.56K | ---- |
-Change in inventory | --1.22M | --655.43K | --1.37M | -1,104.74%-1.78M | ---160.43K | --177.44K | ---219.84K | --513.63K | --115.08K | ---- |
-Change in prepaid assets | ---145.11K | ---1.36M | --31.25K | -109.39%-36.51K | -390.39%-208K | 23.87%388.68K | 1,488.80%490.89K | 526.05%257.67K | -973.85%-458.46K | -111.99%-42.42K |
-Change in payables and accrued expense | ---179.39K | --2.9M | ---513.09K | 172.45%1.88M | -59.43%643.64K | 1,664.14%689.61K | 903.28%293.25K | -30.00%81.38K | 330.91%498.1K | 3,726.62%1.59M |
-Change in other current liabilities | ---2.75M | --371.83K | ---470.83K | 124.19%1.08M | --1.3K | --479.55K | --100.07K | ---88.61K | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | ---105.81K | ---1.1M | ---823.9K | 93.37%-219.31K | 28.33%-2.37M | -1,575.07%-3.31M | -342.38%-423.29K | -215.04%-269.41K | -193.83%-643.32K | -614.11%-3.3M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -91.52K | -1.36M | -93.23K | -21.48%-5.6M | 89.89%-475.27K | -412.28%-4.61M | -5,434.11%-5.08M | 9,575.32%937.68K | -99.86%255 | -686.98%-4.7M |
Net PPE purchase and sale | ---91.52K | ---42.48K | ---93.23K | -1,313.29%-639.47K | ---14.21K | ---45.25K | ---21.14K | ---19.91K | --0 | ---- |
Net intangibles purchas and sale | --0 | ---- | ---- | ---243.2K | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | --0 | ---1.32M | --0 | 6.81%-4.71M | ---245.75K | ---5.06M | ---5.27M | --461.07K | --255 | ---- |
Net investment purchase and sale | ---- | ---- | ---- | --0 | --0 | 155.21%496.53K | --0 | ---- | ---- | -48.15%415.08K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---91.52K | ---1.36M | ---93.23K | -21.48%-5.6M | 89.89%-475.27K | -412.28%-4.61M | -5,434.11%-5.08M | 9,575.32%937.68K | -99.86%255 | -686.98%-4.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 19.67K | -229.88K | 2.58M | 66.58%-220.16K | 27.93%5.03M | -658.7K | -200.33K | -544.79K | -346.94K | 3.93M |
Net issuance payments of debt | --19.67K | ---229.88K | --2.54M | -280.09%-1.43M | --1.3M | ---375.54K | ---200.33K | ---745.68K | ---398.06K | ---- |
Net common stock issuance | --0 | --0 | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --0 | --0 | --33.9K | -41.29%221.28K | -100.00%-1 | --376.89K | --1 | --200.89K | --176K | --371.54K |
Net other financing activities | ---- | ---- | ---- | 249.37%985.95K | ---535.17K | ---660.05K | --0 | --0 | ---124.88K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --19.67K | ---229.88K | --2.58M | 66.58%-220.16K | 27.93%5.03M | ---658.7K | ---200.33K | ---544.79K | ---346.94K | --3.93M |
Net cash flow | ||||||||||
Beginning cash position | --1.4M | --3.7M | --1.93M | -35.57%8.06M | -20.98%6.13M | 34.42%12.51M | 46.75%11.68M | 32.07%11.26M | 49.78%12.51M | -0.06%7.75M |
Current changes in cash | ---177.66K | ---2.68M | --1.66M | 29.61%-6.04M | 153.62%2.18M | -681.78%-8.58M | -3,031.61%-5.7M | 229.41%123.47K | -2,665.84%-990K | -1,305.36%-4.07M |
Effect of exchange rate changes | ---167.8K | --386.26K | --107.82K | -117.16%-92.06K | -216.39%-254.73K | 276.29%536.36K | 900.64%155.88K | 161.35%291.28K | -220.04%-255.22K | -13.38%218.85K |
End cash Position | --1.05M | --1.4M | --3.7M | -56.82%1.93M | 0.00%8.06M | -46.51%4.47M | -20.98%6.13M | 46.75%11.68M | 32.07%11.26M | -3.50%8.06M |
Free cash from | ---197.33K | ---1.14M | ---917.14K | 67.16%-1.1M | 29.08%-2.38M | -1,597.96%-3.36M | -364.47%-444.43K | -238.33%-289.33K | -193.83%-643.32K | -626.05%-3.36M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data